Recruitment of N-Type Ca(2+) channels during LTP enhances low release efficacy of hippocampal CA1 perforant path synapses.
The entorhinal cortex provides both direct and indirect inputs to hippocampal CA1 neurons through the perforant path and Schaffer collateral synapses, respectively. Using both two-photon imaging of synaptic vesicle cycling and electrophysiological recordings, we found that the efficacy of transmitter release at perforant path synapses is lower than at Schaffer collateral inputs. This difference is due to the greater contribution to release by presynaptic N-type voltage-gated Ca(2+) channels at the Schaffer collateral than perforant path synapses. Induction of long-term potentiation that depends on activation of NMDA receptors and L-type voltage-gated Ca(2+) channels enhances the low efficacy of release at perforant path synapses by increasing the contribution of N-type channels to exocytosis. This represents a previously uncharacterized presynaptic mechanism for fine-tuning release properties of distinct classes of synapses onto a common postsynaptic neuron and for regulating synaptic function during long-term synaptic plasticity.
Ahmed
Mohsin S
MS
Department of Neuroscience, Columbia University, New York, NY 10032, USA.
Siegelbaum
Steven A
SA
D015763:2-Amino-5-phosphonovalerate / Q000494:pharmacology; D018750:6-Cyano-7-nitroquinoxaline-2,3-dione / Q000494:pharmacology; D000704:Analysis of Variance; D000818:Animals; D001703:Biophysics; D002121:Calcium Channel Blockers / Q000494:pharmacology; D020864:Calcium Channels, N-Type / Q000502:physiology*; D004305:Dose-Response Relationship, Drug; D004558:Electric Stimulation / Q000379:methods; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology; D019706:Excitatory Postsynaptic Potentials / Q000187:drug effects / Q000502:physiology; D006624:Hippocampus / Q000166:cytology*; D066298:In Vitro Techniques; D007700:Kinetics; D017774:Long-Term Potentiation / Q000187:drug effects / Q000502:physiology*; D051379:Mice; D008810:Mice, Inbred C57BL; D018408:Patch-Clamp Techniques / Q000379:methods; D019580:Perforant Pathway / Q000166:cytology*; D017785:Photons; D011726:Pyridinium Compounds / Q000378:metabolism; D000644:Quaternary Ammonium Compounds / Q000378:metabolism; D011999:Recruitment, Neurophysiological / Q000502:physiology*; D013569:Synapses / Q000187:drug effects / Q000502:physiology*; D013997:Time Factors; D020867:omega-Agatoxin IVA / Q000494:pharmacology
D002121:Calcium Channel Blockers; D020864:Calcium Channels, N-Type; D018691:Excitatory Amino Acid Antagonists; C073804:FM1 43; D011726:Pyridinium Compounds; D000644:Quaternary Ammonium Compounds; D020867:omega-Agatoxin IVA; D018750:6-Cyano-7-nitroquinoxaline-2,3-dione; D015763:2-Amino-5-phosphonovalerate
Trends Neurosci. 2002 Jul;25(7):329-32
12079752
J Neurosci. 2007 Dec 5;27(49):13420-9
18057200
J Neurosci. 1999 Feb 15;19(4):1437-45
9952420
Nature. 2004 Oct 7;431(7009):699-703
15470431
Neuron. 1994 Feb;12(2):261-9
8110457
Neuron. 1999 Dec;24(4):809-17
10624945
Nat Rev Neurosci. 2008 Nov;9(11):813-25
18854855
Hippocampus. 2009 Feb;19(2):187-204
18777561
Nature. 1997 Jul 31;388(6641):478-82
9242407
J Neurosci Methods. 2000 Jan 31;95(1):1-11
10776810
J Neurosci. 2000 Jul 15;20(14):5264-75
10884310
J Neurophysiol. 2001 Oct;86(4):2029-40
11600659
Neuron. 2006 Nov 22;52(4):649-61
17114049
Neuron. 1997 Jun;18(6):995-1008
9208866
J Neurosci. 1991 May;11(5):1375-80
1851219
Nature. 1993 Jan 14;361(6408):165-8
8380626
J Neurosci. 2001 Jun 1;21(11):3721-8
11356859
Science. 1994 Apr 1;264(5155):107-11
7832825
J Neurosci. 2007 Oct 24;27(43):11510-21
17959794
Neuron. 2007 Dec 6;56(5):866-79
18054862
J Neurosci. 1999 Jan 15;19(2):726-36
9880593
Nat Neurosci. 2005 Dec;8(12):1667-76
16299501
Cell. 2004 Nov 24;119(5):719-32
15550252
Science. 2004 Aug 27;305(5688):1258-64
15333832
Nat Neurosci. 2002 Nov;5(11):1185-93
12389030
Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12748-53
11675506
Neuron. 2008 Jan 24;57(2):290-302
18215625
Nature. 1996 Oct 3;383(6599):431-4
8837774
Curr Opin Neurobiol. 2007 Jun;17(3):345-51
17451936
Science. 2002 Jun 21;296(5576):2243-6
12077421
Neuron. 2007 Dec 20;56(6):1076-89
18093528
Neuron. 2009 Apr 30;62(2):242-53
19409269
J Neurophysiol. 2007 Nov;98(5):2779-94
17728392
Nature. 2004 Oct 14;431(7010):796-803
15483601
Annu Rev Physiol. 2002;64:355-405
11826273
Nat Neurosci. 2000 Apr;3(4):330-6
10725921
Philos Trans R Soc Lond B Biol Sci. 2003 Apr 29;358(1432):695-705
12740115
Trends Neurosci. 2006 Nov;29(11):617-24
16942804
Science. 1995 Sep 22;269(5231):1730-4
7569903
Neuropharmacology. 2003 Nov;45(6):828-36
14529720
J Neurosci. 2005 Oct 19;25(42):9567-80
16237162
J Neurosci. 2000 Jan 1;20(1):163-70
10627593
Science. 2008 Feb 29;319(5867):1260-4
18218862
Neuron. 2003 Sep 11;39(6):975-90
12971897
Nature. 2002 Apr 18;416(6882):736-40
11961555
Science. 2006 Aug 25;313(5790):1141-4
16931766
J Neurosci. 2005 Apr 20;25(16):4131-40
15843616
J Neurosci. 2008 Dec 31;28(53):14450-8
19118179
Nat Neurosci. 2004 Sep;7(9):939-46
15311280
Neuron. 2006 May 4;50(3):431-42
16675397
J Neurophysiol. 2006 May;95(5):2962-74
16481459
Neuron. 2003 Jun 5;38(5):797-804
12797963
Nature. 1995 Jun 1;375(6530):404-8
7760934
Nat Neurosci. 2001 Jul;4(7):711-7
11426227
Neuron. 1995 Sep;15(3):675-88
7546746
J Physiol. 1998 Jun 15;509 ( Pt 3):833-45
9596803
Nat Rev Neurosci. 2000 Oct;1(1):41-50
11252767
Learn Mem. 2003 Jul-Aug;10(4):247-52
12888542
Trends Neurosci. 2001 Nov;24(11):637-43
11672807
Neuropharmacology. 2000 Apr 27;39(7):1156-67
10760359
Neuroscience. 2001;102(3):527-40
11226691
Nature. 2002 Jul 18;418(6895):326-31
12124625
Neuron. 2009 Apr 16;62(1):102-11
19376070
Nature. 1994 Oct 20;371(6499):704-7
7935816
Neural Comput. 1999 May 15;11(4):903-17
10226188
Nat Neurosci. 2007 Jun;10(6):691-701
17496890
Neuron. 2007 Jun 7;54(5):801-12
17553427
Science. 1992 Jan 10;255(5041):200-3
1553547
Neuron. 2008 Sep 25;59(6):882-901
18817729